Khrystyna Sorochynska is a regenerative medicine innovator with over a decade of experience in the clinical application of stem cell–based therapies and the design of regenerative treatment strategies. Her expertise focuses on the use of mesenchymal stem cells (MSCs) and exosome-based interventions, with particular emphasis on their immunomodulatory, anti-inflammatory, and tissue-regenerative properties in complex and age-related conditions.
In her current role, she is particularly committed to expanding access to high-safety, scientifically grounded regenerative therapies in the Caribbean region. Her work spans clinical strategy, regulatory compliance, interdisciplinary team training, and the development of collaborative research initiatives aimed at documenting real-world outcomes of MSC and exosome therapies. Through this combination of scientific literacy, practical clinical experience, and regulatory awareness, she seeks to build a sustainable, transparent, and evidence-aligned model of regenerative care for international and regional patients.